Status
Conditions
About
The aim of this study is to determine posture and posture related factors in patients with restrictive and obstructive lung disease.
Full description
It is aimed at investigating posture and posture related factors according to both type of disease and severity of disease in patients with restrictive and obstructive lung disease. The secondary purpose is to develop a model that determines correlations between posture and functional exercise capacity, respiratory and peripheral muscle strength, tightness of muscle, balance, and physical activity for each disease that will be included in this study. In accordance with these purposes, for each group, at least 15 patients with obstructive and restrictive lung disease will be included according to the inclusion and exclusion criteria for each disease, and 15 healthy controls will be included. Tests and questionnaires will be used in order to determine the severity of diseases. Lung function test and respiratory and peripheral muscle strength test will be performed. Time and Go test (TUG) and One minute sit to stand test will be performed. To evaluate the accessory respiratory muscles, a muscle tightness test will be performed for each muscle. Six Minute Walk Test (6 MWT) will be performed with an armband that measures energy expenditure for functional exercise capacity. To evaluate posture, the Corbin Postural Assessment Scale and photographic analysis will be used. Photographical analysis using software in lateral, posterior, and anterior views will be used for the cervical, thoracic, and lumbar regions. For angular and length measurements, anatomical landmarks will be determined and calculated in the regions. According to the results to be obtained, changes in posture according to the regions and posture related factors will be determined for each disease. It will guide professional working in this field.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria:
Chronic Obstructive Pulmonary Disease Group Inclusion Criteria:
Chronic Obstructive Pulmonary Disease Group Exclusion Criteria:
Inclusion Criteria for the Cystic Fibrosis Group:
Cystic Fibrosis Group Exclusion Criteria:
Inclusion Criteria for the Asthma Group:
Asthma Group Exclusion Criteria:
Inclusion Criteria for Bronchiectasis Group:
Bronchiectasis Group Exclusion Criteria:
Diffuse Parenchymal Lung Diseases Inclusion Criteria:
Diffuse Parenchymal Lung Diseases Exclusion Criteria:
90 participants in 3 patient groups
Loading...
Central trial contact
Hidaye Yamikan, PT,MSc; Aynur Demirel, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal